Severity of COVID19 infection among patients with multiple sclerosis treated with interferon-beta

---

Simpson-Yap S., Pirmani A., De Brouwer E., Peeters L. M., Geys L., Parciak T., ...Daha Fazla

MULTIPLE SCLEROSIS AND RELATED DISORDERS, cilt.66, 2022 (SCI-Expanded, Scopus)

• Yayın Türü: Makale / Kısa Makale
• Cilt numarası: 66
• Basım Tarihi: 2022
• Doi Numarası: 10.1016/j.msard.2022.104072
• Dergi Adı: MULTIPLE SCLEROSIS AND RELATED DISORDERS
• Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, EMBASE, MEDLINE
• Hacettepe Üniversitesi Adresli: Evet

Özet

Background: Interferon-beta, a disease-modifying therapy (DMT) for MS, may be associated with less severe COVID-19 in people with MS.